| scholarly article | Q13442814 |
| P356 | DOI | 10.1053/GAST.2003.50148 |
| P698 | PubMed publication ID | 12671894 |
| P50 | author | Christopher Moskaluk | Q57441216 |
| P2093 | author name string | Giorgos Bamias | |
| Fabio Cominelli | |||
| Jesús Rivera-Nieves | |||
| Marco Marini | |||
| Theresa T Pizarro | |||
| Steven M Cohn | |||
| Alda Vidrich | |||
| Marcia J McDuffie | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ileitis | Q3796380 |
| P304 | page(s) | 972-982 | |
| P577 | publication date | 2003-04-01 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis | |
| P478 | volume | 124 |
| Q48152269 | Alterations in the distal colon innervation in Winnie mouse model of spontaneous chronic colitis. |
| Q30436376 | Altered epithelial cell lineage allocation and global expansion of the crypt epithelial stem cell population are associated with ileitis in SAMP1/YitFc mice |
| Q80600314 | Animal models of inflammatory bowel disease |
| Q38218335 | Animal models of inflammatory bowel disease: a review. |
| Q38033380 | Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease |
| Q30429486 | Beta7 integrin deficiency suppresses B cell homing and attenuates chronic ileitis in SAMP1/YitFc mice |
| Q37394024 | Bifidobacterium animalis causes extensive duodenitis and mild colonic inflammation in monoassociated interleukin-10-deficient mice |
| Q35276739 | Central role of IL-17/Th17 immune responses and the gut microbiota in the pathogenesis of intestinal fibrosis |
| Q21131205 | Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics |
| Q49844712 | Comparison of Stromal Vascular Fraction with or Without a Novel Bioscaffold to Fibrin Glue in a Porcine Model of Mechanically Induced Anorectal Fistula |
| Q30439952 | Critical role of endothelial P-selectin glycoprotein ligand 1 in chronic murine ileitis |
| Q51739535 | Death Receptor 3 Signaling Controls the Balance between Regulatory and Effector Lymphocytes in SAMP1/YitFc Mice with Crohn's Disease-Like Ileitis. |
| Q57184753 | Death-Domain-Receptor 3 Deletion Normalizes Inflammatory Gene Expression and Prevents Ileitis in Experimental Crohn's Disease |
| Q22242645 | Defects in mucosal immunity leading to Crohn's disease |
| Q51450213 | Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells. |
| Q28590753 | Elevated expression of Paneth cell CRS4C in ileitis-prone SAMP1/YitFc mice: regional distribution, subcellular localization, and mechanism of action |
| Q30434426 | Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis |
| Q51158560 | Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis. |
| Q30434096 | Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease |
| Q42024414 | Flt3 ligand expands CD103⁺ dendritic cells and FoxP3⁺ T regulatory cells, and attenuates Crohn's-like murine ileitis |
| Q39480560 | Hematopoietic not systemic impairment of Roquin expression accounts for intestinal inflammation in Roquin-deficient mice |
| Q39974669 | IL-33 Drives Eosinophil Infiltration and Pathogenic Type 2 Helper T-Cell Immune Responses Leading to Chronic Experimental Ileitis. |
| Q30311093 | Identification of a quantitative trait locus for ileitis in a spontaneous mouse model of Crohn's disease: SAMP1/YitFc |
| Q37861167 | Immunopathological characteristics of cryptoglandular and Crohn's anorectal fistulas |
| Q31153127 | In vivo demonstration of T lymphocyte migration and amelioration of ileitis in intestinal mucosa of SAMP1/Yit mice by the inhibition of MAdCAM-1. |
| Q41828636 | Induction of a fibrogenic response in mouse colon by overexpression of monocyte chemoattractant protein 1. |
| Q26853123 | Inflammatory bowel disease as a model for translating the microbiome |
| Q64078046 | Intestinal Organoids as a Novel Complementary Model to Dissect Inflammatory Bowel Disease |
| Q57805532 | Intestinal barrier dysfunction orchestrates the onset of inflammatory host-microbiome cross-talk in a human gut inflammation-on-a-chip |
| Q34973958 | Intestinal-specific TNFα overexpression induces Crohn's-like ileitis in mice |
| Q30437758 | Leukocyte adhesion molecules in animal models of inflammatory bowel disease |
| Q30445072 | MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages |
| Q38976561 | Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases |
| Q30310867 | Mouse models for the study of Crohn's disease |
| Q84390175 | Mouse models of intestinal inflammation as tools to understand the pathogenesis of inflammatory bowel disease |
| Q35191071 | Novel cytokine signaling pathways in inflammatory bowel disease: insight into the dichotomous functions of IL-33 during chronic intestinal inflammation |
| Q37206843 | Novel model of TH2-polarized chronic ileitis: the SAMP1 mouse. |
| Q51534901 | Novel therapeutic uses of alpha-1 antitrypsin: a window to the future. |
| Q99636824 | Organoid Models of Colorectal Pathology: Do They Hold the Key to Personalized Medicine? A Systematic Review |
| Q37980400 | Overview of mouse models of inflammatory bowel disease and their use in drug discovery |
| Q94451654 | Paneth cell α-defensin misfolding correlates with dysbiosis and ileitis in Crohn's disease model mice |
| Q33815422 | Paneth cell α-defensins in enteric innate immunity |
| Q93075393 | Pathogenesis of fibrostenosing Crohn's disease |
| Q38593257 | Pathway-based approaches to the treatment of inflammatory bowel disease |
| Q33818370 | Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies |
| Q30425823 | Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism |
| Q30437282 | Probiotics promote gut health through stimulation of epithelial innate immunity |
| Q34008598 | Purinergic receptors in gastrointestinal inflammation |
| Q35872741 | Results of the Fifth Scientific Workshop of the ECCO (II): Pathophysiology of Perianal Fistulizing Disease |
| Q42125930 | Retinoic acid attenuates ileitis by restoring the balance between T-helper 17 and T regulatory cells. |
| Q30440458 | Role of TL1A and its receptor DR3 in two models of chronic murine ileitis |
| Q30438775 | Role of interleukin 6 in a murine model of Crohn's ileitis: are cytokine/anticytokine strategies the future for IBD therapies? |
| Q41899805 | SAMP1/YitFc mice develop ileitis via loss of CCL21 and defects in dendritic cell migration |
| Q30423660 | SAMP1/YitFc mouse strain: a spontaneous model of Crohn's disease-like ileitis |
| Q35070179 | SHIP-deficient mice develop spontaneous intestinal inflammation and arginase-dependent fibrosis |
| Q36511796 | Serum Interleukin-33 level in Saudi children with inflammatory bowel disease |
| Q34602347 | Small intestine inflammation in Roquin-mutant and Roquin-deficient mice |
| Q30423059 | Spontaneous autoimmune gastritis and hypochlorhydria are manifest in the ileitis-prone SAMP1/YitFcs mice |
| Q43110424 | T-bet regulates differentiation of forkhead box protein 3+ regulatory T cells in programmed cell death-1-deficient mice |
| Q30310991 | TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis |
| Q33830064 | Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation |
| Q36219538 | The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation |
| Q34216426 | The immunological and genetic basis of inflammatory bowel disease |
| Q38881849 | The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases |
| Q30439653 | The primary defect in experimental ileitis originates from a nonhematopoietic source |
| Q36914110 | The role of IL-33 in gut mucosal inflammation. |
| Q83185411 | The specific JNK inhibitor SP600125 targets tumour necrosis factor-alpha production and epithelial cell apoptosis in acute murine colitis |
| Q38132555 | The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases. |
| Q36711547 | Tregs are dysfunctional in vivo in a spontaneous murine model of Crohn's disease |
| Q33711741 | Uncovering Pathogenic Mechanisms of Inflammatory Bowel Disease Using Mouse Models of Crohn's Disease-Like Ileitis: What is the Right Model? |
| Q38102750 | Vercirnon for the treatment of Crohn's disease |
| Q51465416 | Well-Known and Less Well-Known Functions of Alpha-1 Antitrypsin. Its Role in Chronic Obstructive Pulmonary Disease and Other Disease Developments. |
Search more.